...
首页> 外文期刊>BioMed research international >Improved Monosegment Pedicle Instrumentation for Treatment of Thoracolumbar Incomplete Burst Fractures
【24h】

Improved Monosegment Pedicle Instrumentation for Treatment of Thoracolumbar Incomplete Burst Fractures

机译:改进的单修椎弓根仪器治疗胸腰椎不完全爆裂裂缝

获取原文
获取原文并翻译 | 示例

摘要

Aim. Comparing the clinical results of improved monosegment pedicle instrumentation (iMSPI) and short-segment pedicle instrumentation (SSPI) retrospectively. Method. 63 patients with thoracolumbar incomplete burst fracture were managed with iMSPI or SSPI. 30 patients were managed with iMSPI and fusion. 33 patients were managed with SSPI and fusion. Operative time, blood loss, postoperative drainage, and complications were recorded. Percentage of anterior body height compression (ABHC%) and sagittal index (SI) were obtained preoperatively, one week postoperatively, and at the last followup. Results. The blood loss and postoperative drainage were significantly less in the iMSPI group than in SSPI group (P < 0.05). The follow-up duration of the two groups was not significantly different (P >0.05). At 12 months postoperatively posterolateral fusion was obtained satisfactorily. Neither preoperative ABHC% and SI nor postoperative SI were significantly different (P >0.05), but there was a significant difference in postoperative ABHC% (P = 0.000). The ABHC% and SI were not significantly different between the two groups at the last followup (P >0.05). There were no fixation failures or other complications. Summary. IMSPI yielded satisfactory results similar to those of SSPI in patients with type A3.1/3.2 thoracolumbar fractures. IMSPI is recommended for minor trauma, reducing one-segment fusion, and maximization of the remaining motor function.
机译:目的。比较改进的单起椎弓根仪表(IMSPI)和短段椎弓根仪器(SSPI)的临床结果。方法。 63例胸瘤不完全破裂骨折的患者用IMSPI或SSPI进行管理。 30名患者用IMSPI和融合进行管理。 33例患者用SSPI和融合进行管理。记录了手术时间,失血,术后引流和并发症。前体高度压缩(ABHC%)和矢状指数(Si)的百分比术前,一周术后,并在最后一次随访中获得。结果。 IMSPI组血液损失和术后引流显着较低,而不是SSPI组(P <0.05)。两组的后续持续时间没有显着差异(p> 0.05)。在术后12个月,令人满意地获得后分离融合。术前ABHC%和Si和术后Si都没有显着差异(P> 0.05),但术后ABHC%(P = 0.000)呈显着差异。 ABHC%和Si在最后一次后续的两组之间没有显着差异(P> 0.05)。没有固定失败或其他并发症。概括。 IMSPI产生令人满意的结果与A3.1 / 3.2胸瘤骨折患者的SSPI类似的结果。建议使用IMSPI进行次要创伤,减少单段融合和剩余电机功能的最大化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号